Re: OPC
|
|
Mannkind
|
Mar 21, 2012 04:20PM
|
Re: Today's Trading
|
|
Mannkind
|
Jun 15, 2012 08:16PM
|
Re: The fools
|
|
Mannkind
|
Jun 20, 2012 06:32PM
|
Re: Outstanding LOC
|
|
Mannkind
|
Aug 29, 2012 12:13PM
|
Re: AstraZeneca to Cut 2,300 Sales Jobs as Research to Narrow
|
|
Mannkind
|
Mar 21, 2013 10:22AM
|
And then there's Adam...
|
|
Mannkind
|
Apr 12, 2013 01:12PM
|
Re: Old class action suit question?
|
|
Mannkind
|
Jun 03, 2013 04:16PM
|
Most active Nasdaq-traded stocks
|
|
Mannkind
|
Jun 17, 2013 02:26PM
|
Re: Today's Trading
|
|
Mannkind
|
Jun 15, 2012 08:17PM
|
Afreeza to decide future course of action for Mankind Corp
|
|
Mannkind
|
Mar 19, 2013 09:36AM
|
Re: More dilution on the way?
|
|
Mannkind
|
Jun 06, 2013 09:54AM
|
Positive results with MannKind's type 1 diabetes drug please investors
|
|
Mannkind
|
Aug 15, 2013 07:27AM
|
Re: Patient Transitioning From Exubera®
|
|
Mannkind
|
Feb 27, 2013 12:08PM
|
Don’t Sweat MannKind Corporation’s (MNKD) Recent Shelf Registration
|
|
Mannkind
|
Sep 06, 2012 10:51AM
|
Is MannKind an Underdog -- or Just a Dog?
|
|
Mannkind
|
Oct 23, 2012 12:32PM
|
Re: We get a mention...
|
|
Mannkind
|
Apr 12, 2012 01:48PM
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 01:33PM
|
Investment Analysts’ Ratings Reiterations for July, 25th
|
|
Mannkind
|
Jul 25, 2012 05:42PM
|
Re: Are These Insiders Telling You to Buy?
|
|
Mannkind
|
Jul 08, 2012 03:37PM
|
Re: Transcript
|
|
Mannkind
|
Aug 09, 2012 05:56PM
|